Text Size

A Prospective Study Comparing the Incidence of Infantile Hemangiomas Following Normal Pregnancies Versus Pregnancies Complicated by Placental Abnormalities

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2007 by Rady Children's Hospital, San Diego.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Rady Children's Hospital, San Diego
ClinicalTrials.gov Identifier:
NCT00490607
First received: June 21, 2007
Last updated: NA
Last verified: June 2007
History: No changes posted
  Purpose

The purpose of this study is to investigate the pathogenesis of hemangiomas of infancy as they relate to normal pregnancies and those pregnancies complicated by placenta abnormalities. Women of all gestational ages will be enrolled in the study. Maternal serum, placental, and cord blood samples will be obtained for each subject. A medical history will be obtained for each subject. Post-delivery a member of the study team will perform a cutaneous exam of the infant to establish what birthmarks are present at birth. Mother will receive four phone call follow ups to determine if the infant has had any skin changes. If yes, mother will be asked to bring the child in for evaluation. If a hemangioma is diagnosed, a blood draw will be performed.


Condition
Hemangioma

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Prospective

Resource links provided by NLM:

MedlinePlus related topics: Birthmarks
U.S. FDA Resources

Further study details as provided by Rady Children's Hospital, San Diego:

  Eligibility

Genders Eligible for Study:   Female
Criteria

Inclusion Criteria:

  • pregnant women delivering at Sharp Mary Birch Hospital for Women in San Diego, CA
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00490607

Locations
United States, California
Sharp Mary Birch Hospital for Women Recruiting
San Diego, California, United States
Contact: Andrea M Munden, BS     858-576-1700 ext 5210     amunden@rchsd.org    
Sponsors and Collaborators
Rady Children's Hospital, San Diego
Investigators
Principal Investigator: Sheila F Friedlander, MA Rady Children's Hospital, San Diego
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00490607     History of Changes
Other Study ID Numbers: Hemangioma Study
Study First Received: June 21, 2007
Last Updated: June 21, 2007
Health Authority: United States: Institutional Review Board

Keywords provided by Rady Children's Hospital, San Diego:
Hemagiomas of infancy

Additional relevant MeSH terms:
Hemangioma
Neoplasms, Vascular Tissue
Neoplasms by Histologic Type
Neoplasms

ClinicalTrials.gov processed this record on May 22, 2013